There is an increasing need for synthetic bone substitute materials that decrease the need for allografts and autografts. In this study, composites of β-tricalcium phosphate and a biodegradable poly(L-lactide-co-ɛ-caprolactone) were manufactured using extrusion to form biodegradable composites with high β-tricalcium phosphate contents for osteoconductivity. The hydrolytic degradation of the composites containing 0, 10, 20, 35 and 50% of β-tricalcium phosphate was studied in vitro for 52 weeks. During the study, it was observed that β-tricalcium phosphate did not have an effect on the degradation rate of the polymer matrix. However, the crystallinity of the materials increased throughout the test series and changes in glass transition temperatures were also observed as the comonomer ratio of the polymer matrix changed as the degradation proceeded. The results show that the materials have desirable degradation properties and, thus, possess great potential as bioabsorbable and osteoconductive bone filling materials.
BernsteinMGotmanIMakarovC. Low temperature fabrication of β-TCP-PCL nanocomposites for bone implants. Adv Eng Mater2010; 12(8): 341–347.
4.
NeumannMEppleM. Composites of calcium phosphate and polymers as bone substitution materials. Eur J Trauma2006; 32(2): 125–131.
5.
NiemeläTKellomäkiMTörmäläP. In vitro degradation of osteoconductive poly-L/DL-lactide/β-TCP composites. Key Eng Mat2004; 254–256: 509–512.
6.
IgnjatovicNUskokovicD. Synthesis and application of hydroxyapatite/polylactide composite biomaterial. Appl Surf Sci2004; 238(1–4 Spec. Iss.): 314–319.
7.
LamCXFTeohSHHutmacherDW. Comparison of the degradation of polycaprolactone and polycaprolactone-(β-tricalcium phosphate) scaffolds in alkaline medium. Polym Int2007; 56(6): 718–728.
8.
OgoseAKondoNUmezuH. Histological assessment in grafts of highly purified beta-tricalcium phosphate (OSferion®) in human bones. Biomaterials2006; 27(8): 1542–1549.
9.
BohnerM. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements. Injury2000; 31(Suppl. 4): D37–D47.
10.
AunobleSClémentDFrayssinetP. Biological performance of a new β-TCP/PLLA composite material for applications in spine surgery: In vitro and in vivo studies. J Biomed Mater Res Pt A2006; 78(2): 416–422.
11.
PuppiDChielliniFPirasAM. Polymeric materials for bone and cartilage repair. Prog Polym Sci (Oxford)2010; 35(4): 403–440.
12.
MalinMHiljanen-VainioMKarjalainenT. Biodegradable lactone copolymers. II. Hydrolytic study of ɛ-caprolactone and lactide copolymers. J Appl Polym Sci1996; 59(8): 1289–1298.
13.
Hiljanen-VainioMKarjalainenTSeppäläJ. Biodegradable lactone copolymers. I. Characterization and mechanical behavior of ɛ-caprolactone and lactide copolymers. J Appl Polym Sci1996; 59(8): 1281–1288.
14.
KarjalainenTHiljanen-VainioMMalinM. Biodegradable lactone copolymers. III. Mechanical properties of ɛ-caprolactone and lactide copolymers after hydrolysis in vitro. J Appl Polym Sci1996; 59(8): 1299–1304.
15.
Hiljanen-VainioMPOravaPASeppalaJV. Properties of ɛ-caprolactone/DL-lactide (ɛ-CL/DL-LA) copolymers with a minor ɛ-CL content. J Biomed Mater Res1997; 34(1): 39–46.
16.
WoodruffMAHutmacherDW. The return of a forgotten polymer – polycaprolactone in the 21st century. Prog Polym Sci (Oxford)2010; 35(10): 1217–1256.
17.
AholaNRichJKarjalainenT. Release of ibuprofen from poly(epsilon-caprolactone-co-D,L-lactide) and simulation of the release. J Appl Polym Sci2003; 88: 1279–1288.
18.
RichJKarjalainenTAhjopaloL. Model compound release from DL-lactide/epsilon-caprolactone copolymers and evaluation of specific interactions by molecular modeling. J Appl Polym Sci2002; 86: 1–9.
19.
GuarinoVAmbrosioL. The synergic effect of polylactide fiber and calcium phosphate particle reinforcement in poly ɛ-caprolactone-based composite scaffolds. Acta Biomater2008; 4(6): 1778–1787.
20.
FabbriPCannilloVSolaA. Highly porous polycaprolactone-45S5 Bioglass® scaffolds for bone tissue engineering. Compos Sci Technol2010; 70(13): 1869–1878.
21.
ErdemliOÇaptugOBilgiliH. In vitro and in vivo evaluation of the effects of demineralized bone matrix or calcium sulfate addition to polycaprolactone-bioglass composites. J Mater Sci Mater Med2010; 21(1): 295–308.
22.
DengCYaoNLuX. Comparison of Ca/P mineralization on the surfaces of poly (ɛ-caprolactone) composites filled with silane-modified nano-apatite. J Mater Sci2009; 44(16): 4394–4398.
23.
SongHVan QuangDMinY. Effect of the addition of t-ZrO2 on the material properties of β-TCP/PCL composites. J Mater Sci2008; 43(13): 4450–4454.
24.
XiaoXLiuRHuangQ. Preparation and characterization of hydroxyapatite/polycaprolactone-chitosan composites. J Mater Sci Mater Med2009; 20(12): 2375–2383.
25.
YeoARaiBSjuE. The degradation profile of novel, bioresorbable PCL-TCP scaffolds: an in vitro and in vivo study. J Biomed Mater Res Pt A2008; 84(1): 208–218.
26.
LeiYRaiBHoKH. In vitro degradation of novel bioactive polycaprolactone-20% tricalcium phosphate composite scaffolds for bone engineering. Mater Sci Eng C2007; 27(2): 293–298.
27.
International Organization for Standardization, Implants for surgery – copolymers and blends based in polylactide – in vitro degradation testing, ISO 15814:1999(E), International Organization for Standardization, 1999, Geneva, Switzerland.
28.
International Organization for Standardization, Water quality – determination of phosphorus – ammonium molybdate spectrometric method, ISO 6878:2004, International Organization for Standardization, 2004, Geneva, Switzerland.
29.
CottamEHukinsDWLLeeK. Effect of sterilisation by gamma irradiation on the ability of polycaprolactone (PCL) to act as a scaffold material. Med Eng Phys2009; 31(2): 221–226.
30.
SödergårdAStoltM. Properties of lactic acid based polymers and their correlation with composition. Prog Polym Sci (Oxford)2002; 27(6): 1123–1163.
31.
DaculsiGGoyenvalleECognetR. Osteoconductive properties of poly(96 L/4D-lactide)/beta-tricalcium phosphate in long term animal model. Biomaterials2011; 32(12): 3166–3177.
32.
PaakinahoKElläVSyrjäläS. Melt spinning of poly(l/d)lactide 96/4: effects of molecular weight and melt processing on hydrolytic degradation. Polym Degrad Stabil2009; 94(3): 438–442.
33.
In JeongSKimBLeeYM. Morphology of elastic poly(L-lactide-co-ɛ-caprolactone) copolymers and in vitro and in vivo degradation behavior of their scaffolds. Biomacromolecules2004; 5(4): 1303–1309.
34.
FernándezJEtxeberriaASarasuaJ. Synthesis, structure and properties of poly(L-lactide-co-ɛ-caprolactone) statistical copolymers. J Mech Behav Biomed Mater2012; 9: 100–112.
35.
HerbertIRStatistical analysis of copolymer sequence distribution. In: IbbetRN (eds). NMR spectroscopy of polymers, London: Blackie Academic & Professional, 1993, pp. 50–79.
36.
LiS. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomed Mater Res1999; 48(3): 342–353.
37.
SawhneyASHubbellJA. Rapidly degraded terpolymers of dl-lactide, glycolide, and ɛ-caprolactone with increased hydrophilicity by copolymerization with polyethers. J Biomed Mater Res1990; 24(10): 1397–1411.
38.
LiSGarreauHVertM. Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media – Part 3 influence of the morphology of poly(l-lactic acid). J Mater Sci: Mater Med1990; 1(4): 198–206.
39.
LinFChenTLinC. The merit of sintered PDLLA/TCP composites in management of bone fracture internal fixation. Artif Organs1999; 23(2): 186–194.
40.
AraMWatanabeMImaiY. Effect of blending calcium compounds on hydrolytic degradation of poly(DL-lactic acid-co-glycolic acid). Biomaterials2002; 23(12): 2479–2483.
41.
RagaertKDekeyserACardonL. Quantification of thermal material degradation during the processing of biomedical thermoplastics. J Appl Polym Sci2011; 120(5): 2872–2880.
42.
PittCGPoly-ɛ-caprolactone and its copolymers. In: ChasinMLangerR (eds). Biodegradable polymers as drug delivery systems, New York, NY: Marcel Dekker Inc., 1990, pp. 71–120.
43.
SarasuaJPrud'hommeREWisniewskiM. Crystallization and melting behavior of polylactides. Macromolecules1998; 31(12): 3895–3905.
44.
ShoreECHolmesEPorous hydroxyapatite. In: HenchLLWilsonJ (eds). An introduction to bioceramics, Singapore: World Scientific Publishing, 1993, pp. 181–198.
